MedTrace Logo

Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users

NCT04763018 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-02-21

No results posted yet for this study

Summary

Two study arms - sham and treatment; There will be a cross over of the sham group to the treatment group at day 15.

Conditions

  • Visual Display Users With Previously Undiagnosed Dry Eye

Interventions

DEVICE

iTEAR100

Neurostimulation external nasal nerve to stimulate tear production

Sponsors & Collaborators

  • Olympic Ophthalmics, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-17
Primary Completion
2021-05-01
Completion
2021-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04763018 on ClinicalTrials.gov